- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07733011
Comparison of Computer-Assisted and Conventional Local Anesthesia in Children With Molar-Incisor Hypomineralization
Comparison of Computer-Assisted and Conventional Local Anesthesia in Children With Molar-Incisor Hypomineralization: A Split-Mouth Randomized Controlled Clinical Trial
The main questions this study aims to answer are:
Does computer-controlled local anesthesia cause less pain and anxiety than conventional local anesthesia in children with molar-incisor hypomineralization (MIH)?
Is there a difference between the two methods in anesthesia onset time, injection duration, physiological responses, and the need for additional anesthesia?
Researchers will compare computer-controlled and conventional local anesthesia in children aged 8-12 years with MIH. Each child will receive both anesthesia methods during separate dental visits, on comparable permanent molar teeth, to determine which method is more comfortable, effective, and preferred by children.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized split-mouth clinical trial will compare computer-controlled local anesthesia with conventional local anesthesia in children aged 8-12 years with molar-incisor hypomineralization (MIH).
Each child will receive both anesthesia methods during separate restorative treatment visits on comparable affected permanent molars. Pain will be evaluated using child-reported and behavioral pain scales. Dental anxiety, heart rate, oxygen saturation, anesthesia onset time, injection duration, need for additional anesthesia, and patient preference will also be assessed.
The study aims to determine whether computer-controlled local anesthesia provides a more comfortable and effective option than conventional anesthesia for children with MIH.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Betül Şen Yavuz, DDS
- Phone Number: +905399887646
- Email: dtbetulsen@gmail.com
Study Locations
-
-
Maltepe
-
Istanbul, Maltepe, Turkey (Türkiye), 34854
- Marmara Üniversitesi Recep Tayyip Erdoğan Külliyesi Sağlık Yerleşkesi, Diş Hekimliği Fakültesi
-
Contact:
- Betul Sen Yavuz
- Phone Number: +905399887646
- Email: dtbetulsen@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged 8-12 years
- Children with no systemic disease
- Children with no pathology involving the oral region, such as trauma, cysts, or tumors
- Children who have not used antibiotics within the past month
- Children who have not used nonsteroidal anti-inflammatory drugs (NSAIDs) within the past month
- Children with at least two homologous permanent molars affected by molar-incisor hypomineralization (MIH) and indicated for restorative treatment due to dentin caries
- Children with a Frankl Behavior Rating Scale score of 3 or higher will be included in the study
Exclusion Criteria:
- Children in whom local anesthesia cannot be administered due to lack of cooperation
- Children who require pulp treatment after enrollment in the study will be withdrawn from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computer-Controlled Local Anesthesia
Local anesthesia will be administered using the SleeperOne computer-controlled local anesthetic delivery system according to the manufacturer's pediatric protocol.
The device electronically controls the injection flow rate and pressure.
A 4% articaine solution with 1:100,000 epinephrine will be used before restorative treatment of the MIH-affected permanent molar.
|
Local anesthesia will be administered using the SleeperOne computer-controlled local anesthetic delivery system according to the manufacturer's pediatric protocol.
The device electronically controls the flow rate and pressure of the anesthetic solution.
A 4% articaine solution with 1:100,000 epinephrine will be administered before restorative treatment of the MIH-affected permanent molar.
Other Names:
|
|
Active Comparator: Conventional Local Anesthesia
Local anesthesia will be administered using a conventional dental syringe.
Buccal infiltration will be used for maxillary teeth, and an inferior alveolar nerve block will be used for mandibular teeth.
A 4% articaine solution with 1:100,000 epinephrine will be administered before restorative treatment of the MIH-affected permanent molar.
|
Local anesthesia will be administered using a conventional dental syringe.
Buccal infiltration will be used for maxillary teeth, and an inferior alveolar nerve block will be used for mandibular teeth.
A 4% articaine solution with 1:100,000 epinephrine will be administered before restorative treatment of the MIH-affected permanent molar.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Injection pain assessed using the Wong-Baker Faces Pain Rating Scale
Time Frame: Immediately after completion of local anesthetic injection at each treatment visit
|
Pain intensity will be assessed during local anesthetic injection using the Wong-Baker Faces Pain Rating Scale (score range: 0-10; higher scores indicate greater pain).
|
Immediately after completion of local anesthetic injection at each treatment visit
|
|
Injection pain assessed using the Visual Analog Scale (VAS)
Time Frame: Immediately after completion of local anesthetic injection at each treatment visit
|
Pain intensity will be assessed immediately after local anesthetic injection using a 100-mm Visual Analog Scale (0=no pain, 100=worst imaginable pain; higher scores indicate greater pain).
|
Immediately after completion of local anesthetic injection at each treatment visit
|
|
Behavioral pain assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) Scale
Time Frame: Periprocedural (during local anesthetic injection at each treatment visit)
|
Behavioral pain will be assessed during local anesthetic injection using the Face, Legs, Activity, Cry, Consolability (FLACC) Scale (score range: 0-10; higher scores indicate greater pain).
|
Periprocedural (during local anesthetic injection at each treatment visit)
|
|
Successful local anesthesia during restorative treatment
Time Frame: Immediately after completion of restorative treatment at each treatment visit
|
Successful local anesthesia will be defined as completion of cavity preparation and restorative treatment without the need for supplemental local anesthesia and without interruption of treatment because of pain.
The outcome will be reported as the percentage of treatment visits with successful local anesthesia.
|
Immediately after completion of restorative treatment at each treatment visit
|
|
Absence of response to electric pulp testing
Time Frame: Immediately after completion of local anesthetic injection at each treatment visit
|
The proportion of treatment visits in which no response is obtained using an electric pulp tester after local anesthetic administration.
|
Immediately after completion of local anesthetic injection at each treatment visit
|
|
Anesthesia Onset Time
Time Frame: Immediately following local anesthetic injection at each treatment visit.
|
Anesthesia onset time will be compared between computer-controlled and conventional local anesthesia.
It will be defined as the time from completion of the injection until the child reports numbness and no response is obtained with electric pulp testing.
The time will be recorded in seconds.
|
Immediately following local anesthetic injection at each treatment visit.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- tezasli2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.